Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

28-Oct-16 - 26-Oct-17
Buy Ratio:43%

Up

# Net Buyers:133
# Net Sellers:179

Previous 52 Weeks

30-Oct-15 - 27-Oct-16
Buy Ratio:41%
# Net Buyers:138
# Net Sellers:196
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
China Biologic Products, Inc.($14.63M)$1.54B  
Zoetis Inc.($5.29M)$785.77M  
Colucid Pharmaceuticals, Inc.$715.81M$720.00M  
Catalent, Inc.($13.81M)$607.33M  
Anacor Pharmaceuticals, Inc.--$231.28M  
New Net Buyers
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.$715.81M$720.00M  
Acceleron Pharma Inc$2.99M$49.95M  
Biogen Inc.$7.98M$28.83M  
Amicus Therapeutics Inc$19.47M$27.72M  
Acorda Therapeutics Inc$12.68M$18.81M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Mylan N.V.($1.83B)($1.82B)  
Kite Pharma, Inc.($745.30M)($722.74M)  
Incyte Corp($44.78M)($260.90M)  
Seattle Genetics Inc /wa$68.99M($188.99M)  
Acadia Pharmaceuticals Inc($15.68M)($170.04M)  
New Net Sellers
CompanyNet Buy AmountChange
Incyte Corp($44.78M)($260.90M)  
Acadia Pharmaceuticals Inc($15.68M)($170.04M)  
Global Blood Therapeutics, Inc.($99.82M)($99.88M)  
Nexvet Biopharma Plc($76.62M)($78.18M)  
Portola Pharmaceuticals Inc($38.31M)($73.97M)